U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H38N
Molecular Weight 304.5331
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of BENZODODECINIUM ION

SMILES

CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1

InChI

InChIKey=CYDRXTMLKJDRQH-UHFFFAOYSA-N
InChI=1S/C21H38N/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21/h13-15,17-18H,4-12,16,19-20H2,1-3H3/q+1

HIDE SMILES / InChI

Molecular Formula C21H38N
Molecular Weight 304.5331
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Benzododecinium, a quaternary ammonium compound, is an antiseptic agent and disinfectant. Benzododecinium is used as preservative in different pharmaceutical formulations. Thus, the dispenser of Timoptol-LA, used for the treatment of patients with ocular hypertension, contains benzododecinium bromide as a preservative. It is used as preservative and the corneal permeability enhancer in formulation. Benzododecinium is effective against gram-positive microbes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Counterion effects on interaction of amphiphilic quaternary ammonium salts with model membranes.
2001 May-Jun
Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
2001 Nov
Mikrocalorimetric studies on the interaction of N-dodecyl-N,N-dimethyl-N-benzylammonium halides with phosphatidylcholine bilayers: a counterion effect.
2002
Interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers-the effect of counterions.
2003 Apr
Bactericidal treatment of raw cotton as the method of byssinosis prevention.
2003 Jan-Feb
Sterol and sterolin-containing products: hematologic adverse reactions.
2004 Apr 13
Analysis of benzyldimethyldodecylammonium bromide in chemical disinfectants by liquid chromatography and capillary electrophoresis.
2004 Jun 11
Architecture of the hydrophobic and hydrophilic layers as found from crystal structure analysis of N-benzyl-N,N-dimethylalkylammonium bromides.
2005 Oct 1
Identification of benzalkonium chloride in commercial grapefruit seed extracts.
2005 Sep 21
Molecular mechanism and thermodynamics study of plasmid DNA and cationic surfactants interactions.
2006 Apr 11
Measuring quaternary ammonium cleaning agents with ion selective electrodes.
2006 Jun 16
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
2006 Mar 27
The influence of cholesterol on the interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers.
2006 Mar-Apr
[Inactivation of mycobacteria by disinfectants with a tuberculocidal label].
2006 May
Instrument processing with lauryl dimethyl benzyl ammonium bromide: a challenge for patient safety.
2008 Oct
Speciation of scandium and gallium in soil.
2008 Sep
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide: II. Volumetric properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009 Feb 15
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide I. Surface properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009 Mar 15
Synthesis of macroporous thermosensitive hydrogels: a novel method of controlling pore size.
2009 Mar 3
In situ forming polymeric drug delivery systems.
2009 May
Biofouling control using microparticles carrying a biocide.
2010
Sorption of quaternary ammonium compounds to municipal sludge.
2010 Apr
The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections.
2010 Dec
Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface.
2010 Dec
Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension.
2010 Jul 21
[Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
2010 Jun
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The design proposed the optimized batch by selecting the independent variables as gellan gum (0.55% w/v), carbopol 934P (0.35% w/v) and benzododecenium bromide (0.013% w/v) to achieve the maximum viscosity
Ophthalmic use: The 25 uL of test sample was instilled in the lower conjunctival sac of eye and holded for 10 seconds.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: The mechanism of action of benzyldimethyldodecylammonium chloride (Benzododecinium chloride) was assessed against Pseudomonas fluorescens.
The MIC was found to be 20 mg/L and the MBC was 10 mg/L
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:15:30 GMT 2023
Edited
by admin
on Fri Dec 15 17:15:30 GMT 2023
Record UNII
N0BN0O8CSL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZODODECINIUM ION
Common Name English
Benzododecinium [WHO-DD]
Common Name English
BENZODODECINIUM
WHO-DD  
Common Name English
BENZYLDODECYLDIMETHYLAMMONIUM
Systematic Name English
BENZODODECINIUM CATION
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
WHO-VATC QD09AA05
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
WHO-ATC D09AA05
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
Code System Code Type Description
EVMPD
SUB00724MIG
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
PUBCHEM
8754
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
FDA UNII
N0BN0O8CSL
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
SMS_ID
100000085019
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
EPA CompTox
DTXSID60872947
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
RXCUI
1311593
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
NCI_THESAURUS
C79723
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
MESH
C015163
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
CHEBI
135611
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
DAILYMED
N0BN0O8CSL
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
DRUG BANK
DB13282
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
CAS
10328-35-5
Created by admin on Fri Dec 15 17:15:30 GMT 2023 , Edited by admin on Fri Dec 15 17:15:30 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY